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The objective of the present study was to develop stomach-
specific drug delivery system of rifabutin and to evaluate their 
effectiveness in eradication of Helicobacter pylori in 
experimental Mongolian gerbil model. 
Rifabutin loaded floating gellan gum beads prepared by 
calcium induced ionotropic gelation in acidic medium. The 
prepared beads were evaluated for in vitro characterization and 
in vivo Helicobacter pylori clearance efficiency following 
repeated oral administration to Helicobacter pylori infected 
Mongolian gerbils. Our results showed that the rifabutin loaded 
floating beads possess significant anti- Helicobacter pylori 
effect in the in vivo gerbil model.  
The findings support that rifabutin floating beads could be a 
promising gastrointestinal drug delivery system in treatment of 
Helicobacter pylori. 




It is estimated that more than half-human 
population has infected with Helicobacter pylori 
[1]. Most people are unaware that they are 
infected because they remain asymptomatic 
throughout life and survive without any harmful 
infection-related clinical consequences. However, 
some develop duodenal or gastric ulcers and a 
small proportion are diagnosed with lymphoma 
or gastric malignancy [2]. Helicobacter pylori are 
specifically suited to the colonization of the 
human stomach, in which it causes an 
inflammatory reaction and epithelial damage with 
cellular swelling and cytoplasmic Vacuolation, 
both in vivo and in vitro. The two main bacterial 
factors involved in this cellular damage are 
urease and vacuolating toxin A [3]. Ammonia 
produced by urease action potentiates the action  
 
 
of vacuolating toxin A to Vacuolation in 
stomach. Ammonia crosses cell membranes in an 
uncharged state, is trapped by protonation within 
acidic intracellular compartments, and thereafter 
induces osmotic swelling of these compartments, 
which in turn causes cell Vacuolation.  
Rifabutin, a spiropiperidyl derivative of 
Rifamycin, has been shown to exhibit high in 
vitro activity against Helicobacter pylori [4, 5]. It 
inhibits Helicobacter pylori growth in vitro at 
very low concentrations [6]; therefore, it may be 
indicated in addition to second line therapy as 
well as in first line therapy in H. pylori infection. 
In the present study, we investigated the efficacy 
of rifabutin loaded floating gellan beads in the 
treatment of Helicobacter pylori infected 
experimental Mongolian gerbils. 
 





Material and methods 
Materials 
Rifabutin was obtained from Henan Kangtai 
Pharm Group, China. Deacetylated gellan gum 
(Kelcogel) was obtained as a gift sample from CP 
Kelco UK Ltd, Surrey, U.K. De-ionized water 
(HPLC grade) purchased from Quilagens, India. 
All other chemicals purchased were of analytical 
or microbiological grade. Helicobacter pylori 
strain NCTC 11637 was obtained from IVRI, 
Bareilly, India. 
 
Methods of Preparation of Floating Beads 
The beads, whose composition is shown in Table 
1, were prepared by ionotropic gelation technique 
[7] with some modification. Gellan solution (1--
3%w/v) was prepared by dissolving the gellan in 
deionized water by at 90 °C. The drug, rifabutin, 
and sodium bicarbonate were dissolved/dispersed 
uniformly in gellan solution at or just below 40 
°C under continuous stirring. Stirring was 
continued until a uniform dispersion was 
obtained. The bubble free slurry (dispersion) was 
added drop wise into gelation medium consisting 
of varying concentration of Ca2+ in 10%v/v acetic 
acid using 25ml hypodermic syringe through a 
20G needle. This medium was continuously 
stirred during bead formation to enhance the 
mechanical strength of the beads and also to 
prevent their aggregation. The beads were cured 
for 5 min, separated by filtration, washed thrice 
with deionized and dried at 40 °C in a hot air 
oven (DR 101, Universal, India).  
 
In vitro buoyancy of the beads 
In-vitro study of bead buoyancy was performed 
using a USP dissolution apparatus type II (paddle 
type, Electrolab, Mumbai, India). The beads were 
dispersed in 500ml of 0.01M HCl (pH 2.0) at 
37±10C with continuous agitation at 50 rpm for 
24 h. The floating beads were separated from 
submerged beads and their proportion was 




Determination of drug contents and 
entrapment efficiency of floating beads 
The drug contents and entrapment efficiency of 
each formulation was determined by first 
extracting rifabutin from an accurately weighed 
quantity (100 mg) of the beads using 0.01M HCl 
(pH 2.0) and determining the amount of the drug 
by high performance liquid chromatography 
(HPLC). For HPLC determination of drug, the 
mobile phase consisted of 0.05M potassium 
dihydrogen phosphate and 0.05M sodium acetate 
(pH adjusted to 4.0 with acetic acid)/acetonitrile 
(53:47, v/v) at a flow rate of 1 ml/min at 25 °C. 
The HPLC system (Shimadzu, SPD-20A 
detector, LC-20AT pump) consisted of a UV 
detector set to 275 nm. The analytical column 
was A Pursuit XRs C-8 column (USP-L7). 
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A standard solution of rifabutin (100μg/ml) was 
prepared by weighing the appropriate amount of 
bulk rifabutin and dissolving it in the mobile 
phase. Further stock solutions were made by 
diluting the initial stock standard solution with 
mobile phase. A seven-point calibration curve 
ranging from 1 to 7 μg /ml were used for the 
quantification of rifabutin. A stock solution of 1.0 
μg/ml was stored at −30 °C and a sample of this 
stock solution was always injected together with 
the analyzed samples to verify the precision of 
the obtained concentrations of rifabutin in 
samples and controls from their peak area- 
concentration response. 
 
Cultivation of Helicobacter pylori 
Solid media were used for growth of strains 
before inoculation of liquid media. H pylori 
isolates and strain NCTC 11637 were subcultured 
on chocolate agar plates with 7% sheep blood. 
The medium was supplemented with 2,500 U/ml 
of Polymyxin B, 5 mg/l of Trimetoprim and 5 
mg/l of Amphotericin B (Fluka, Switzerland). 
The agar plates were incubated at 37oC for 3-5 
days under microaerophillic conditions (4% 
Oxygen, 5% Hydrogen, 5% Carbon-di-oxide, and 
86% Nitrogen) in a Carbon Dioxide Incubator 
(Khera Instruments, India). The identification of 
Helicobacter pylori was done on the basis of 
colonial morphology (1–2 mm, small and 
translucent colonies), microscopically (the 
presence of curved Gram-negative cells) and by 
positive urease reaction. Gram stain with carbol-
fuchsin was used for microscopic examination. 
Liquid media used for a series of studies were 
based on brain heart infusion broth (with 5% 
horse serum and 0 25% yeast extract (HIMEDIA 
Laboratories, India). Cultures from chocolate 
agar plates were inoculated into 5 ml aliquots of 
nutrient broth to achieve graded concentrations of 
bacterial cells, determined by comparator 
turbidity tubes (McFarland No 0-5-No 5). Each 
suspension (1 ml) was transferred to a 200 
milliliter tissue culture flask containing 100 ml 
prewarmed liquid medium. The flasks were 
incubated at 37oC for 3-5 days under 
microaerophillic conditions (4% Oxygen, 5% 
Hydrogen, 5% Carbon-di-oxide, and 86% 
Nitrogen) in a Carbon Dioxide Incubator. The 
cultures were examined daily for viable cell 
counts, and the urease test and Gram stain were 
also used. Oxidase and catalase tests were also 
used to out rule contamination. Dilutions of 10-1 , 
10-3, and 10-4 were made from the tissue culture 
flasks by suspending the culture in nutrient broth. 
The suspensions were inoculated with a 1 µl 
calibrated loop on to chocolate agar plates in 
triplicate. The plates were incubated as described 
above and colonies counted after five days of 
incubation. The mean value of three readings was 
calculated and expressed as colony forming units 
per milliliter (CFU/ml). 
 
Animals and Groupings 
Male 5-wk-old male Mongolian gerbils weighing 
30-40 g (Central Drug Research Institute, 
Lucknow, India) were acclimated to the housing 
facilities for 5 days before initiation of the study. 
Free access to standard pellet chow was allowed 
throughout the experimental protocol, with the 
exception of overnight fasting before induction of 
Helicobacter pylori infection. The Animal Care 
and Use Committee of College of Pharmacy, 
IFTM, Moradabad India where the study was 
conducted approved all protocols. Infection was 
induced by giving the Helicobacter pylori 
inoculums of 2 ml (1 x 108 H. Pylori/ ml) orally 
every alternate for seven days. Two month after 
confirming the infection, a total 30 Mongolian 
gerbils were divided into five equal groups (n=6 
each group). Group I (control group) animals 
were given floating gellan gum beads (without 
drug), Group II, Group III and Group IV (treated) 
animals were given floating beads containing 
rifabutin equivalent to 2 mg/k.g, p.o, 4 m.g/k.g, 
p.o and 6mg/k.g. p.o respectively for 7 days 
whereas Group V were given rifabutin 
suspension equivalent 6mg /kg in 0.4%w/v gellan 
gum.  
 
Helicobacter pylori Clearance study 
One day after administration of the final dose, the 
Mongolian gerbils were sacrificed and the 
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homogenized with Brucella broth (3 ml/stomach), 
and serial dilutions were plated on modified 
Skirrow’s medium. The agar plates were 
incubated for 4 days at 37 °C under 
microaerophillic environment in a carbon dioxide 
incubator. The viable cell counts for each 
stomach determined by counting the number of 
colonies on the agar plates. The colonies were 
identified as Helicobacter pylori by morphology 
and urease activity. The number of colonies per 
plate was counted and expressed as log CFU 
(Colony Forming Units) per gastric wall. The 
advantage of this evaluation method is that errors 
caused by sampling site variation can be avoided 
because the whole stomach is used to determine 
the bacterial cell count. 
 
Morphological Evaluation and Histopathology 
Gastric tissues collected from Mongolian gerbils 
in each group, stained with Giemsa Stain 
followed by serial slide from Mongolian gerbils 
in each group with hematoxilin-eosin (HE) and 
then observed under light microscope at 200x or 
400-x magnification. 
 
SYTO 9 Dye Staining 
This method allows visualization of cells with 
intact (‘live’) cell membrane [9]. The fluorescent 
stain is a green SYTO 9 dye (Bio Source, USA). 
SYTO 9 dyes bind to DNA and penetrate the cell 
membrane.  Green SYTO 9 passes readily 
through the intact membrane and under the 
fluorescent microscope the intact (‘live’) cells 
thus emit green light.  
 
Statistics 
All the data were analyzed by Student’s t test and 
one-way ANOVA to determine statistical 
difference in the results. A probability value p < 
0.05 was considered statistically significant. The 




In vitro floating properties: 
As Table 2 shows, the floating properties of the 
formulation depended largely on sodium 
bicarbonate. While the control beads (without 
sodium bicarbonate) sank completely in the 
medium, the beads containing 0.4 % NaHCO3 
demonstrated good floating characteristics. There 
was no lag time as the beads floated immediately 
when placed in 0.01M hydrochloric acid and 
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Entrapment efficiency of floating beads 
Rifabutin entrapment ranged from 41.12% to 
59.78% (Table 2). Drug entrapment efficiency 
varied with polymer content and the calcium 
concentration of the gelation medium. Increase in 
calcium concentration enhanced drug entrapment 
efficiency (p< 0.05) (compare batches A1and A3, 
A4 and A6 and A7 and A9). Similarly, as the 
concentration of gellan gum rose, entrapment 
efficiency also increased (compare A1 and A7; 
and A2 and A8). Overall, however, the rifabutin 
entrapment efficiency of the beads was low. 
 






Figure 1. (a) Shows the normal histopathology of stomach of M. gerbils without any sign of ulcer without infection of H. Pylori 
(H.E x 100). (b) Shows the distorted glandular architecture with overlying the fibrous tissue with numerous H. pylori after 4 
months infected M. gerbils (H.E. x 400) (control Group).  (c) Shows the glandular architecture with marginal vein slightly 
inflamed but no sign of bleeding after treatment with rifabutin 6 mg/kg  for 7 days of  2 months infected of  M. Gerbils by H. 
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Helicobacter clearance study 
Activities of Helicobacter pylori clearance were 
7.11± 0.316 and 2.40± 0.271 at a dose of 2 and 4 
mg /kg rifabutin from floating beads (formulation 
A1) respectively (p< 0.05 2mg/kg compared to 
4mg/kg)), whereas placebo group showed 
maximum count of Helicobacter pylori (p<0.05 
compared to 2mg/kg and 4mg/kg treated groups). 
Complete eradication of Helicobacter pylori was 
observed at a dose of rifabutin 6 mg /kg body 
weight whereas rifabutin suspension of 6 mg /kg 
body weight did not show complete eradication 
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SYTO 9 Dye Staining 
In order to strengthen our findings regarding the 
clearance of Helicobacter pylori from infected 
Mongolian gerbils, we have carried out SYTO 9 
staining to get information about the live intact 
cells before and after the treatment with rifabutin 




Figure 2. (a) Live staining of H. Pylori of control group 
shows green-stained viable cells (200x). 
 
 
Figure 2. (b) Shows decreases viable of H. Pylori after 
treatment with rifabutin beads 6       mg/kg body weight 




Rifabutin loaded floating gellan gum beads 
The numerous pores in the bead interior may be 
directly related to the presence of sodium 
bicarbonate (figure was and is in agreement with 
the findings of Choi et al [8]. The increase in 
bead size with increasing gellan concentration 
could be attributed to increase in microviscosity 
of the polymeric dispersion, leading eventually to 
the formation of bigger beads [10].  
 
              
Figure.3: Scanning electron microscope images transverse 
section, of rifabutin- loaded  bead. 
 
The low drug entrapment efficiency of the beads 
may be due to the use of sodium bicarbonate as 
gas-generating agent, which reacting with acetic 
acid releases carbon dioxide. The released carbon 
dioxide gets entrapped in the gel network, thus 
increasing bead porosity and decreasing the 
strength of the bead wall. As a result, the drug 
readily diffuses out into the gelation fluid. 
Stockwell and Davis [11] also reported the low 
entrapment efficiency of alginate beads due to 
violent gas generation. 
 
Figure.4. (a) Entrapment efficiency of floating beads.  (b) Effect of increasing polymer concentration on Entrapment 
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The increase in the drug entrapment efficiency of 
beads with increasing polymer concentration may 
be because increase in the gellan concentration 
resulted in the formation of larger beads which 
entrapped more drug (figure 4). Furthermore, 
higher polymer concentration affords higher 
viscosity, which would hinder easy escape of the 
drug from the polymer matrix to the gelation 
medium. 
 
Helicobacter clearance studies 
Helicobacter pylori are gram-negative rods found 
in the human gastric mucosa and associated with 
digestive disease and causative bacteria of active 
chronic gastritis, a main factor in the peptic ulcer 
and a risk factor in the development of gastric 
cancer [12]. Since 1994 it has been considered, a 
class 1 carcinogen by IARC (World Health 
Organization). The organism is also involved in 
the developments of Mucosa Associated 
Lymphoid Tissue (MALT) and several other 
published reports exist which associate it with 
extra-digestive diseases [13, 14]. Therapeutic 
efficacy in Helicobacter pylori infections always 
has been problematic. Helicobacter pylori are 
microorganisms, capable of surviving in highly 
acidic condition. As a result, chronic infection 
generally develops, thus requiring prolonged 
therapy [15].  
 
In the present investigation, the effects of 
rifabutin floating beads were investigated in 
Helicobacter pylori infection in Mongolian 
gerbils. The reason for choosing gellan gum as 
carrier for rifabutin was its excellent 
biocompatibility. Although PLGA polymers were 
also considered during the process of selection of 
polymer, as these are also biocompatible but were 
rejected because their biodegradation resulted in 
acidic components viz. lactic acid and glycolic 
acid and Helicobacter pylori are reported to be 
susceptible in acidic medium, therefore PLGA 
polymers were not considered for formulation 
development. 
 
Our results showed that ulcer produced by 
Helicobacter pylori was significantly reduced in 
size (p< 0.05) after treatment of rifabutin 6 mg/ 
kg and bacterial count reached non detectable 
levels after treatment of one week. The reduction 
in ulcer size could be attributed to the inhibition 
of Helicobacter pylori due to rifabutin therapy 
which might have resulted in the absence of 
causative factors for ulcer, that is, urease and 
vacuolating toxin A [3]. The results obtained 
were well supported by findings from SYTO 9 
staining which showed almost absence live 
Helicobacter pylori after treatment.  Earlier study 
showed that long-term therapies are required for 
eradication of Helicobacter pylori but failed to 
reach the baseline level even after 4 weeks after 
treatment [15]. Therefore, the rifabutin beads 
showed effective treatment strategy for 
Helicobacter pylori infection in short- time.  
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